Renalytix - Return on Investment 2020-2024 | RNLXY

Current and historical return on investment (ROI) values for Renalytix - (RNLXY) over the last 10 years.
Renalytix - ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $-0.02B $-0.01B 480.00%
2024-06-30 $-0.03B $0.00B 1288.89%
2024-03-31 $-0.03B $-0.01B -1466.67%
2023-12-31 $-0.04B $0.00B -380.00%
2023-09-30 $-0.04B $0.00B -271.19%
2023-06-30 $-0.04B $0.01B -215.00%
2023-03-31 $-0.05B $0.03B -176.92%
2022-12-31 $-0.05B $0.02B -253.16%
2022-09-30 $-0.05B $0.03B -342.86%
2022-06-30 $-0.05B $0.04B -568.42%
2022-03-31 $-0.05B 0.00%
2021-12-31 $-0.04B -220.00%
2021-09-30 $-0.04B -93.41%
2021-06-30 $-0.03B -50.39%
2021-03-31 $-0.03B $0.08B -37.04%
2020-12-31 $-0.02B $0.09B -42.11%
2020-09-30 $-0.01B $0.09B -54.37%
2020-06-30 $-0.01B $0.02B -275.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.029B $0.002B
Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.738B 59.46
Hims & Hers Health (HIMS) United States $12.987B 134.93
Doximity (DOCS) United States $11.457B 53.04
Tempus AI (TEM) United States $11.228B 0.00
IRhythm Technologies (IRTC) United States $4.298B 0.00
Inspire Medical Systems (INSP) United States $3.880B 60.62
Hinge Health (HNGE) United States $3.671B 0.00
Privia Health (PRVA) United States $2.475B 169.17
Clover Health Investments (CLOV) United States $1.735B 0.00
Schrodinger (SDGR) United States $1.690B 0.00
10x Genomics (TXG) United States $1.677B 0.00
Phreesia (PHR) United States $1.648B 0.00
Enovis (ENOV) United States $1.582B 8.82
Azenta (AZTA) United States $1.578B 73.36
Omnicell (OMCL) United States $1.321B 23.31
Evolent Health (EVH) United States $1.199B 102.10
Claritev (CTEV) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.575B 0.00
Standard BioTools (LAB) United States $0.551B 0.00
Butterfly Network (BFLY) United States $0.532B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Talkspace (TALK) United States $0.438B 131.00
TruBridge (TBRG) United States $0.347B 770.33
Outset Medical (OM) United States $0.345B 0.00
Health Catalyst (HCAT) United States $0.282B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.197B 0.00
Zepp Health (ZEPP) Netherlands $0.176B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.134B 0.00
MDxHealth SA (MDXH) Belgium $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
CareCloud (CCLD) United States $0.105B 3.98
Insight Molecular Diagnostics (IMDX) United States $0.086B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00